FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 156

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
DSNKY Over the counter Daiichi Sankyo Company, Limited 2834
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2834
ENGN Nasdaq enGene Holdings Inc. 2834
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2834
ENVB Nasdaq Enveric Biosciences, Inc. 2834
FBRX Nasdaq Forte Biosciences, Inc. 2834
GERN Nasdaq Geron Corporation 2834
GNTA Nasdaq Genenta Science S.p.A. 2834
GRCE Nasdaq Grace Therapeutics, Inc. 2834
HCM Nasdaq HUTCHMED (China) Limited 2834
HEPA Nasdaq Hepion Pharmaceuticals, Inc. 2834
HLN New York Haleon plc 2834
IBIO Nasdaq iBio, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
IMUX Nasdaq Immunic, Inc. 2834
IMVT Nasdaq Immunovant, Inc. 2834
INDV Nasdaq Indivior PLC 2834
INKT Nasdaq MiNK Therapeutics, Inc. 2834
IOBT Nasdaq IO Biotech, Inc. 2834
JAGX Nasdaq Jaguar Health, Inc. 2834
JANX Nasdaq Janux Therapeutics, Inc. 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KNSA Nasdaq Kiniksa Pharmaceuticals International, p 2834
KROS Nasdaq Keros Therapeutics, Inc. 2834
KRYS Nasdaq Krystal Biotech, Inc. 2834
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2834
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2834
LEXX Nasdaq Lexaria Bioscience Corp. 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
LIPO Nasdaq Lipella Pharmaceuticals Inc. 2834
LSB Nasdaq LakeShore Biopharma Co., Ltd 2834
LXEO Nasdaq Lexeo Therapeutics, Inc. 2834
LYRA Nasdaq Lyra Therapeutics, Inc. 2834
LZAGY Over the counter Lonza Group AG 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MAZE Nasdaq Maze Therapeutics, Inc. 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MLTX Nasdaq MoonLake Immunotherapeutics 2834
MLYS Nasdaq Mineralys Therapeutics, Inc. 2834
MRK New York Merck & Co., Inc. 2834
MTSR Nasdaq Metsera, Inc. 2834
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2834
NMRA Nasdaq Neumora Therapeutics, Inc. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NVCT Nasdaq Nuvectis Pharma, Inc. 2834
NVS New York Novartis AG 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCS Nasdaq Oculis Holding AG 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
OMER Nasdaq Omeros Corporation 2834
Results 50 through 100 of 156